Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Small Vessels Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05671770
What this trial is testing

Study Based on Electronic Health RecOrds to Identify Patients at High-risk of Fabry DiseasE (HOPE Fabry)

Who this might be right for
Fabry Disease
Sanofi 15
Not applicableUnknownNCT01712282
What this trial is testing

Physical Activity Immediately After Acute Cerebral Ischemia 3

Who this might be right for
Acute Ischemic Stroke
Hillerod Hospital, Denmark 20
Not applicableStudy completedNCT05746624
What this trial is testing

Procedural Motor Memory in Long COVID-19

Who this might be right for
Infectious Metabolic EncephalopathyIschemic StrokeSeizure+1 more
National Institute of Neurological Disorders and Stroke (NINDS) 333
Large-scale testing (Phase 3)Active Not RecruitingNCT05280548
What this trial is testing

Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease

Who this might be right for
Fabry Disease
Sanofi 104
Large-scale testing (Phase 3)Active Not RecruitingNCT04020055
What this trial is testing

Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease

Who this might be right for
Fabry Disease
Amicus Therapeutics 14
Not applicableUnknownNCT04943991
What this trial is testing

Fabry Disease in High-risk Patients With Left Ventricular Hypertrophy: Prevalence and Implementation of a Clinical Score

Who this might be right for
Fabry DiseaseFabry Disease, Cardiac VariantLysosomal Storage Diseases+2 more
Wuerzburg University Hospital 200
Not applicableLooking for participantsNCT02967068
What this trial is testing

VCRC Tissue Repository

Who this might be right for
AortitisCutaneous VasculitisEosinophilic Granulomatosis With Polyangiitis+8 more
University of Pennsylvania 1,000
Not applicableLooking for participantsNCT06643013
What this trial is testing

Targeting 18kDa Translocator Protein (TSPO) to Improve Brain Endothelial Cell Function in Cerebral Small Vessel Disease

Who this might be right for
Cerebral Small Vessel Disease
Imperial College London 106
Large-scale testing (Phase 3)Study completedNCT02194985
What this trial is testing

Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease

Who this might be right for
Fabry Disease
Amicus Therapeutics 84
Testing effectiveness (Phase 2)Study completedNCT06072118
What this trial is testing

Adrenomedullin for CADASIL

Who this might be right for
Cadasil
National Cerebral and Cardiovascular Center, Japan 60
Not applicableUnknownNCT00349024
What this trial is testing

Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChordomaKidney Cancer+7 more
Children's Cancer and Leukaemia Group 50
Not applicableNot Yet RecruitingNCT07726654
What this trial is testing

The Longitudinal Cohort of Cerebral Small Vessel Disease in Ruijin Hospital

Who this might be right for
Cerebral Small Vessel Disease
Ruijin Hospital 400
Large-scale testing (Phase 3)Study completedNCT00074971
What this trial is testing

The Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

Who this might be right for
Fabry Disease
Genzyme, a Sanofi Company 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT06961344
What this trial is testing

An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)

Who this might be right for
Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
Tisento Therapeutics 44
Not applicableLooking for participantsNCT05971446
What this trial is testing

Healthy Little Eyes

Who this might be right for
Hypoxic-Ischemic EncephalopathyNeonatal EncephalopathyEncephalopathy
University of Wisconsin, Madison 125
Not applicableStudy completedNCT04602364
What this trial is testing

French Prospective, Observational Cohort Study of Patients With Fabry Disease Treated With Migalastat

Who this might be right for
Fabry Disease
Amicus Therapeutics France SAS 48
Not applicableStudy completedNCT05408130
What this trial is testing

Remote Ischemic Conditioning With Novel Optical Sensor Feedback Device in Acute Ischemic Stroke

Who this might be right for
Stroke, Acute IschemicSmall Vessel Cerebrovascular Disease
University of Alberta 51
Early research (Phase 1)Study completedNCT03888716
What this trial is testing

A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease

Who this might be right for
Mitochondrial DiseasesMitochondrial Respiratory Chain DeficienciesMELAS Syndrome+1 more
Abliva AB 72
Not applicableStudy completedNCT02190916
What this trial is testing

Vasculitis Illness Perception (VIP) Study

Who this might be right for
Wegener GranulomatosisMicroscopic PolyangiitisChurg-Strauss Syndrome+6 more
University of South Florida 707
Not applicableStudy completedNCT01198899
What this trial is testing

Belgian Screening Project for the Detection of Anderson-Fabry Disease in Hypertrophic Cardiomyopathy

Who this might be right for
Left Ventricular Hypertrophy
University Hospital, Ghent 540
Next Page